Volume 23 - Issue 1 - January 2015

A recent population-based, cohort study found that while patients with psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) are all at an elevated risk for major adverse cardiovascular events (MACE), the severity of cardiovascular (CV) risk varies among the diseases and varies depending on treatment.
Mary Frances Pilcher, MD, FAAD, and Arlene Rogachefsky, MD, FAAD
Joseph R. Kallini, MD, and Amor Khachemoune, MD, FAAD, FACMS
Sarah L. Taylor, MD, MPH, and Steven R. Feldman, MD, PhD
Section Editor, Benjamin Barankin, MD, FRCPC